Medigraph Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 16-11-2024
- Paid Up Capital ₹ 2.40 M
as on 16-11-2024
- Company Age 29 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.31 Cr
as on 16-11-2024
- Satisfied Charges ₹ 2.50 Cr
as on 16-11-2024
- Revenue -26.95%
(FY 2023)
- Profit -67.06%
(FY 2023)
- Ebitda -64.14%
(FY 2023)
- Net Worth 10.98%
(FY 2023)
- Total Assets 16.96%
(FY 2023)
About Medigraph Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.40 M.
The company currently has active open charges totaling ₹2.31 Cr. The company has closed loans amounting to ₹2.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
Pankaj Chaudhari and Pranay Goel serve as directors at the Company.
- CIN/LLPIN
U24239MH1995PTC086316
- Company No.
086316
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Mar 1995
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Medigraph Pharmaceuticals Private Limited offer?
Medigraph Pharmaceuticals Private Limited offers a wide range of products and services, including API Intermediate, Chemical Intermediates, Intermediate Chemicals.
Who are the key members and board of directors at Medigraph Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pankaj Chaudhari  | Director | 08-Dec-2012 | Current |
| Pranay Goel | Director | 10-Mar-1995 | Current |
Financial Performance of Medigraph Pharmaceuticals.
Medigraph Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 26.95% decrease. The company also saw a substantial fall in profitability, with a 67.06% decrease in profit. The company's net worth Soared by an impressive increase of 10.98%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medigraph Pharmaceuticals?
Unlock access to Medigraph Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Pioneer Agro Industries Sanvin Laboratories Private LimitedActive 37 years 5 months
Pranay Goel is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 28 Feb 2024 | ₹3.07 M | Open |
Hdfc Bank Limited Creation Date: 03 Dec 2022 | ₹2.00 Cr | Open |
Hdfc Bank Limited Creation Date: 07 Nov 2020 | ₹2.50 Cr | Satisfied |
How Many Employees Work at Medigraph Pharmaceuticals?
Medigraph Pharmaceuticals has a workforce of 2 employees as of Oct 11, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medigraph Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medigraph Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
